Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reiji Yoshimura

Showing results (261-270 of 297) with videos related to

Pageof 30
Sort By:
Journal of Affective Disorders|June 14, 2011
Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese populationYasuhisa Fukuo, Taro Kishi, Itaru Kushima, et al.
Neuropharmacology|February 25, 2010
Association analysis of SIGMAR1 with major depressive disorder and SSRI responseTaro Kishi, Reiji Yoshimura, Tomo Okochi, et al.
Journal of Affective Disorders|July 10, 2012
GTP cyclohydrolase 1 gene haplotypes as predictors of SSRI response in Japanese patients with major depressive disorderTaro Kishi, Hiroshi Ichinose, Reiji Yoshimura, et al.
Journal of Affective Disorders|May 11, 2010
SIRT1 gene is associated with major depressive disorder in the Japanese populationTaro Kishi, Reiji Yoshimura, Tsuyoshi Kitajima, et al.
Annals of Medicine|June 16, 2023
Costs of psychotropics for outpatients with bipolar disorder in Japan; the MUSUBI 2016 surveyNaoto Adachi, Yukihisa Kubota, Eiichiro Goto, et al.
Neuromolecular Medicine|May 15, 2010
Lack of association between MAGEL2 and schizophrenia and mood disorders in the Japanese populationYasuhisa Fukuo, Taro Kishi, Tomo Okochi, et al.
Hiroshima Journal of Medical Sciences|April 23, 2013
The valproate serum level in maintenance therapy for bipolar disorder in JapanAkihiko Machino, Hiroaki Jitsuiki, Yasumasa Okamoto, et al.
Neuropsychiatric Disease and Treatment|April 14, 2020
Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI)Takashi Tsuboi, Takefumi Suzuki, Takaharu Azekawa, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|October 30, 2020
Factors Associated with Doses of Mood Stabilizers in Real-world Outpatients with Bipolar DisorderNorio Yasui-Furukori, Naoto Adachi, Yukihisa Kubota, et al.
Human Psychopharmacology|October 22, 2020
Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients' and practitioners' parameters in the MUSUBI studyNaoto Adachi, Takaharu Azekawa, Kouji Edagawa, et al.
Pageof 30

Showing results (261-270 of 297) with videos related to

Sort By:
Pageof 30
Journal of Affective Disorders|June 14, 2011
Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese populationYasuhisa Fukuo, Taro Kishi, Itaru Kushima, et al.
Neuropharmacology|February 25, 2010
Association analysis of SIGMAR1 with major depressive disorder and SSRI responseTaro Kishi, Reiji Yoshimura, Tomo Okochi, et al.
Journal of Affective Disorders|July 10, 2012
GTP cyclohydrolase 1 gene haplotypes as predictors of SSRI response in Japanese patients with major depressive disorderTaro Kishi, Hiroshi Ichinose, Reiji Yoshimura, et al.
Journal of Affective Disorders|May 11, 2010
SIRT1 gene is associated with major depressive disorder in the Japanese populationTaro Kishi, Reiji Yoshimura, Tsuyoshi Kitajima, et al.
Annals of Medicine|June 16, 2023
Costs of psychotropics for outpatients with bipolar disorder in Japan; the MUSUBI 2016 surveyNaoto Adachi, Yukihisa Kubota, Eiichiro Goto, et al.
Neuromolecular Medicine|May 15, 2010
Lack of association between MAGEL2 and schizophrenia and mood disorders in the Japanese populationYasuhisa Fukuo, Taro Kishi, Tomo Okochi, et al.
Hiroshima Journal of Medical Sciences|April 23, 2013
The valproate serum level in maintenance therapy for bipolar disorder in JapanAkihiko Machino, Hiroaki Jitsuiki, Yasumasa Okamoto, et al.
Neuropsychiatric Disease and Treatment|April 14, 2020
Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI)Takashi Tsuboi, Takefumi Suzuki, Takaharu Azekawa, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|October 30, 2020
Factors Associated with Doses of Mood Stabilizers in Real-world Outpatients with Bipolar DisorderNorio Yasui-Furukori, Naoto Adachi, Yukihisa Kubota, et al.
Human Psychopharmacology|October 22, 2020
Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients' and practitioners' parameters in the MUSUBI studyNaoto Adachi, Takaharu Azekawa, Kouji Edagawa, et al.
Pageof 30